Abstract
BackgroundThe recruitment of clinical trial participants in a timely manner is one of the greatest obstacles to developing the next Huntington’s disease (HD) treatment. In the past, if individuals were...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Neurology, Neurosurgery & Psychiatry
Paper Title
Journal
Date
